These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26947596)

  • 1. Beneficial Effects of Exercise-Based Cardiac Rehabilitation on High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity in Patients with Acute Coronary Syndrome.
    Koba S; Ayaori M; Uto-Kondo H; Furuyama F; Yokota Y; Tsunoda F; Shoji M; Ikewaki K; Kobayashi Y
    J Atheroscler Thromb; 2016 Jul; 23(7):865-77. PubMed ID: 26947596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome.
    Furuyama F; Koba S; Yokota Y; Tsunoda F; Shoji M; Kobayashi Y
    J Atheroscler Thromb; 2018 Feb; 25(2):153-169. PubMed ID: 28855433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of exercise-based cardiac rehabilitation on non-culprit mild coronary plaques in the culprit coronary artery of patients with acute coronary syndrome.
    Kurose S; Iwasaka J; Tsutsumi H; Yamanaka Y; Shinno H; Fukushima Y; Higurashi K; Imai M; Masuda I; Takeda S; Kawai C; Kimura Y
    Heart Vessels; 2016 Jun; 31(6):846-54. PubMed ID: 25896129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
    Hafiane A; Jabor B; Ruel I; Ling J; Genest J
    Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.
    Khera AV; Cuchel M; de la Llera-Moya M; Rodrigues A; Burke MF; Jafri K; French BC; Phillips JA; Mucksavage ML; Wilensky RL; Mohler ER; Rothblat GH; Rader DJ
    N Engl J Med; 2011 Jan; 364(2):127-35. PubMed ID: 21226578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study.
    Soria-Florido MT; Castañer O; Lassale C; Estruch R; Salas-Salvadó J; Martínez-González MÁ; Corella D; Ros E; Arós F; Elosua R; Lapetra J; Fiol M; Alonso-Gómez A; Gómez-Gracia E; Serra-Majem L; Pintó X; Bulló M; Ruiz-Canela M; Sorlí JV; Hernáez Á; Fitó M
    Circulation; 2020 Feb; 141(6):444-453. PubMed ID: 31941372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Exercise Capacity and Health-Related Quality of Life During and After Cardiac Rehabilitation in Acute Coronary Syndrome Patients: A Substudy of the OPTICARE Randomized Controlled Trial.
    de Bakker M; den Uijl I; Ter Hoeve N; van Domburg RT; Geleijnse ML; van den Berg-Emons RJ; Boersma E; Sunamura M
    Arch Phys Med Rehabil; 2020 Apr; 101(4):650-657. PubMed ID: 31904342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.
    Ray KK; Ditmarsch M; Kallend D; Niesor EJ; Suchankova G; Upmanyu R; Anzures-Cabrera J; Lehnert V; Pauly-Evers M; Holme I; Štásek J; van Hessen MW; Jones P;
    Eur Heart J; 2014 Jul; 35(27):1792-800. PubMed ID: 24639426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Density Lipoprotein Particles, Cell-Cholesterol Efflux, and Coronary Heart Disease Risk.
    Asztalos BF; Horvath KV; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2007-2015. PubMed ID: 30002062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy.
    Boyer M; Lévesque V; Poirier P; Marette A; Mitchell PL; Mora S; Mathieu P; Després JP; Larose É; Arsenault BJ
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a cardiac rehabilitation program and inflammatory state on endothelial progenitor cells in acute coronary syndrome patients.
    Cesari F; Marcucci R; Gori AM; Burgisser C; Francini S; Sofi F; Gensini GF; Abbate R; Fattirolli F
    Int J Cardiol; 2013 Sep; 167(5):1854-9. PubMed ID: 22626841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis.
    Ormseth MJ; Yancey PG; Solus JF; Bridges SL; Curtis JR; Linton MF; Fazio S; Davies SS; Roberts LJ; Vickers KC; Kon V; Michael Stein C;
    Arthritis Rheumatol; 2016 Sep; 68(9):2099-105. PubMed ID: 26991245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes: a randomized controlled trial.
    Yudi MB; Clark DJ; Tsang D; Jelinek M; Kalten K; Joshi SB; Phan K; Ramchand J; Nasis A; Amerena J; Koshy AN; Murphy AC; Arunothayaraj S; Si S; Reid CM; Farouque O
    Coron Artery Dis; 2021 Aug; 32(5):432-440. PubMed ID: 32868661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate- and High-Intensity Exercise Improves Lipoprotein Profile and Cholesterol Efflux Capacity in Healthy Young Men.
    Stanton KM; Kienzle V; Dinnes DLM; Kotchetkov I; Jessup W; Kritharides L; Celermajer DS; Rye KA
    J Am Heart Assoc; 2022 Jun; 11(12):e023386. PubMed ID: 35699182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.
    Diditchenko S; Gille A; Pragst I; Stadler D; Waelchli M; Hamilton R; Leis A; Wright SD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2202-11. PubMed ID: 23868939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aerobic training on exercise capacity and quality of life in patients older than 75 years with acute coronary syndrome undergoing percutaneous coronary intervention.
    Deng B; Shou X; Ren A; Liu X; Wang Q; Wang B; Wang Y; Yan T; Zhao X; Zhu L
    Physiother Theory Pract; 2022 Sep; 38(9):1135-1144. PubMed ID: 32991232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac rehabilitation in patients with acute coronary syndrome with primary percutaneous coronary intervention is associated with improved 10-year survival.
    Sunamura M; Ter Hoeve N; van den Berg-Emons RJG; Boersma E; van Domburg RT; Geleijnse ML
    Eur Heart J Qual Care Clin Outcomes; 2018 Jul; 4(3):168-172. PubMed ID: 29325067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
    Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
    Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHA2DS2-VASc score and exercise capacity of patients with coronary artery disease participating in cardiac rehabilitation programs.
    Haskiah F; Shacham Y; Minha S; Rozenbaum Z; Pereg D
    Coron Artery Dis; 2017 Dec; 28(8):697-701. PubMed ID: 28857776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.
    Patel PJ; Khera AV; Wilensky RL; Rader DJ
    Eur J Heart Fail; 2013 Nov; 15(11):1215-9. PubMed ID: 23709232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.